Skip to main content
Clinical Trials/NL-OMON28887
NL-OMON28887CompletedPhase 4

Efficacy of Pectoral Nerve (PECS II) Block for Breast Conserving Surgery: A Prospective Randomized Controlled Trial

St. Antonius Hospital0 sites200 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
200

Study Overview

Brief Summary

/A

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria: - Female gender. - Unilateral breast conserving surgery. - Written informed consent according to ICH/GCP and national regulations. - ASA (American Society of Anesthesiologists) Class I-III .

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded from participation in this study: - Women < 18 year old. - Bilateral surgery. - Bleeding disorder or coagulopathy. - Chest wall deformity or infection of injection site. - Another (additional) nerve block (such as TPVB or epidural anesthesia). - Oncoplastic breast conserving surgery. - Autologous or implant based breast reconstruction. - Known allergy for levobupivacaine or local anesthetics from the amide group. - Chronic use of analgesics / opiates preoperatively (> 12 weeks). - Previous breast surgery ipsi- or contralateral (except diagnostic biopsies). - Not able to speak or understand the Dutch language fluently. - Palliative surgery. - Metastatic disease. - Pregnancy or breast feeding. - Psychological, neurological, familial, sociological or geographical factors that could potentially hamper compliance with the study protocol. - Other concurrent solid tumor.

Investigators

Similar Trials

Efficacy of Pectoral Nerve (PECS II) Block... | Clinical Trial